William W. Stoops

5.1k total citations
168 papers, 3.8k citations indexed

About

William W. Stoops is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Pharmacology. According to data from OpenAlex, William W. Stoops has authored 168 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Cellular and Molecular Neuroscience, 54 papers in Epidemiology and 41 papers in Pharmacology. Recurrent topics in William W. Stoops's work include Neurotransmitter Receptor Influence on Behavior (96 papers), Substance Abuse Treatment and Outcomes (50 papers) and Forensic Toxicology and Drug Analysis (31 papers). William W. Stoops is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (96 papers), Substance Abuse Treatment and Outcomes (50 papers) and Forensic Toxicology and Drug Analysis (31 papers). William W. Stoops collaborates with scholars based in United States, Belgium and Canada. William W. Stoops's co-authors include Craig R. Rush, Justin C. Strickland, Joshua A. Lile, Paul E.A. Glaser, Lon R. Hays, Andrea R. Vansickel, Mark T. Fillmore, Jennifer R. Havens, Katherine R. Marks and Erika Pike and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pharmacological Reviews and Neuroscience & Biobehavioral Reviews.

In The Last Decade

William W. Stoops

159 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William W. Stoops United States 35 1.9k 935 729 726 702 168 3.8k
John Grabowski United States 35 1.7k 0.9× 1.1k 1.2× 774 1.1× 1.0k 1.4× 463 0.7× 85 3.8k
Gantt P. Galloway United States 34 1.6k 0.8× 1.1k 1.2× 656 0.9× 655 0.9× 553 0.8× 77 3.7k
Robert Malcolm United States 44 1.9k 1.0× 1.2k 1.3× 1.1k 1.6× 1.1k 1.6× 805 1.1× 140 6.0k
John D. Roache United States 40 2.1k 1.1× 1.7k 1.9× 1.1k 1.5× 952 1.3× 829 1.2× 166 5.8k
Henri‐Jean Aubin France 33 905 0.5× 1.1k 1.2× 563 0.8× 356 0.5× 631 0.9× 139 4.7k
Mehmet Sofuoglu United States 49 3.0k 1.6× 1.2k 1.3× 1.2k 1.7× 822 1.1× 846 1.2× 204 7.6k
James Poling United States 35 1.2k 0.6× 1.2k 1.3× 811 1.1× 595 0.8× 276 0.4× 69 4.1k
Ismene L. Petrakis United States 46 2.5k 1.3× 1.5k 1.6× 1.2k 1.6× 984 1.4× 917 1.3× 177 6.4k
Sara L. Simon United States 21 1.3k 0.7× 779 0.8× 421 0.6× 557 0.8× 874 1.2× 30 3.5k
Carl L. Hart United States 45 2.2k 1.1× 929 1.0× 2.2k 3.0× 581 0.8× 1.3k 1.8× 100 5.4k

Countries citing papers authored by William W. Stoops

Since Specialization
Citations

This map shows the geographic impact of William W. Stoops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William W. Stoops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William W. Stoops more than expected).

Fields of papers citing papers by William W. Stoops

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William W. Stoops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William W. Stoops. The network helps show where William W. Stoops may publish in the future.

Co-authorship network of co-authors of William W. Stoops

This figure shows the co-authorship network connecting the top 25 collaborators of William W. Stoops. A scholar is included among the top collaborators of William W. Stoops based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William W. Stoops. William W. Stoops is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knudsen, Hannah K., et al.. (2025). Drug use and disability: A call to action. Drug and Alcohol Dependence. 271. 112637–112637.
2.
Bergeria, Cecilia L., Cassandra D. Gipson, Kirsten E. Smith, William W. Stoops, & Justin C. Strickland. (2024). Opioid craving does not incubate over time in inpatient or outpatient treatment studies: Is the preclinical incubation of craving model lost in translation?. Neuroscience & Biobehavioral Reviews. 160. 105618–105618. 9 indexed citations
3.
Lile, Joshua A., et al.. (2024). Adapting a Functional Assessment of Cigarette Smoking for People with Intellectual and Developmental Disabilities. Behavior Analysis in Practice. 18(1). 137–149.
4.
McGinty, Jacqueline F., Victoria Arango, Kathleen T. Brady, et al.. (2024). Will the promise of translational neuropsychopharmacology research ever deliver? The lion’s roar; the kitten’s purr. PubMed. 2(1). 4–4.
5.
Stoops, William W., David Cox, Lon R. Hays, et al.. (2024). Influence of cocaine use reduction on markers of immune function. Journal of Neuroimmunology. 397. 578470–578470.
6.
Beckmann, Joshua S., et al.. (2023). Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine. Neuropharmacology. 245. 109816–109816. 9 indexed citations
7.
Mei, Hong, et al.. (2023). Oxycodone withdrawal is associated with increased cocaine self-administration and aberrant accumbens glutamate plasticity in rats. Neuropharmacology. 242. 109773–109773. 5 indexed citations
8.
Lile, Joshua A., et al.. (2022). Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis. Journal of Addiction Medicine. 17(2). e87–e93. 1 indexed citations
9.
Lile, Joshua A., Joseph L. Alcorn, Lon R. Hays, et al.. (2021). Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users.. Experimental and Clinical Psychopharmacology. 30(5). 560–574. 6 indexed citations
10.
Strickland, Justin C., et al.. (2020). An evaluation of fixed and randomized price sequence on the alcohol purchase task.. Experimental and Clinical Psychopharmacology. 29(4). 295–301. 5 indexed citations
11.
Lile, Joshua A., Matthew L. Banks, Kevin W. Hatton, et al.. (2019). Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys.. Experimental and Clinical Psychopharmacology. 28(2). 169–180. 29 indexed citations
12.
Strickland, Justin C., Joshua A. Lile, & William W. Stoops. (2017). Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand. Behavioural Processes. 140. 33–40. 69 indexed citations
13.
Lile, Joshua A., William W. Stoops, Craig R. Rush, et al.. (2016). Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug and Alcohol Dependence. 165. 111–119. 33 indexed citations
14.
Marks, Katherine R., et al.. (2015). Laboratory drug administration does not increase use in the natural ecology immediately following study discharge. Drug and Alcohol Dependence. 156. e140–e140. 1 indexed citations
15.
Reynolds, Brady, et al.. (2015). A feasibility study of home-based contingency management with adolescent smokers of rural Appalachia.. Experimental and Clinical Psychopharmacology. 23(6). 486–493. 37 indexed citations
16.
Stoops, William W. & Craig R. Rush. (2013). Agonist Replacement for Stimulant Dependence: A Review of Clinical Research. Current Pharmaceutical Design. 19(40). 7026–7035. 49 indexed citations
17.
Stoops, William W., et al.. (2011). Influence of escalating alternative reinforcer values on cigarette choice. Behavioural Processes. 87(3). 302–305. 10 indexed citations
18.
Stoops, William W., Michele Staton Tindall, Jennifer R. Havens, et al.. (2007). Kentucky Rural Stimulant Use: A Comparison of Methamphetamine and Other Stimulant Users. Journal of Psychoactive Drugs. 39(sup4). 407–417. 7 indexed citations
19.
Rush, Craig R., Stephen T. Higgins, Andrea R. Vansickel, et al.. (2005). Methylphenidate increases cigarette smoking. Psychopharmacology. 181(4). 781–789. 51 indexed citations
20.
Rush, Craig R., et al.. (2003). Risperidone Attenuates the Discriminative-Stimulus Effects of d-Amphetamine in Humans. Journal of Pharmacology and Experimental Therapeutics. 306(1). 195–204. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026